QNRXQuoin Pharmaceuticals Ltd. American Depositary Shares

5.570USDMkt Cap: 11.19M $P/E:

Quoin Pharmaceuticals, Ltd., a late-stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases in the United States. The company's lead p…

Key Statistics

Company
Market Cap11.19M $
Enterprise Value-1.65M $
Revenue (TTM)
Gross Profit
Net Income (TTM)-15.80M $
Revenue/Share
Last Price5.570 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees4
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN
Valuation
P/E (Trailing)
P/E (Forward)-1.57
PEG
EV/EBITDA0.10
EV/Revenue
P/S
P/B0.57
EPS (TTM)-6.08
EPS (Forward)-3.19
52W Range
5.02064% of range5.880
52W High5.880 USD
52W Low5.020 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-120.46%
ROA-77.51%
Growth
Revenue Growth
Earnings Growth
Cash Flow & Leverage
Operating CF-13.54M $
CapEx (TTM)
FCF Margin
FCF Yield-84.39%
Net Debt-11.87M $
Net Debt/EBITDA0.68
Balance Sheet
Debt/Equity24.78
Current Ratio2.87
Quick Ratio2.63
Book Value/Sh8.756 USD
Cash/Share6.992 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay DateOct 23, 2019
Splits
Last Split1:35
Split DateApr 9, 2025
Analyst Consensus
Rating1.3 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)21.40 USD
Upside (mean)+284.2%
Target Range12.00 USD35.00 USD
$12.00+284.2% to mean$35.00
# Analysts5
Ownership
Shares Out.2.01M
Float1.63M
Insiders2.63%
Institutions61.64%
Short Interest
Short Ratio4.0d
Short % Float5.79%
Short % Out.5.77%
Shares Short115.83K
Short (prev mo.)261.88K
Technical
SMA 504.576 (+21.7%)
SMA 2008.265 (-32.6%)
Beta1.66
S&P 52W Chg21.00%
Avg Vol (30d)71.85K
Avg Vol (10d)26.93K
Technical Indicators
RSI (14)60.5
MACD0.2033
MACD Signal0.1804
MACD Hist.+0.0230
BB Upper5.983 USD
BB Middle4.866 USD
BB Lower3.750 USD
BB Width45.88%
ATR (14)0.4968 USD
Vol Ratio (20d)3.71x